Logo
Contact    |    Site Map    |    Careers

 

Board of Directors


 

Marc A. Cohen, Chairman

Chairman & CEO, OPNET Technologies, Bethesda, MD (Nasdaq: OPNT), and Member of the Board of Trustees, Dana-Farber Cancer Institute

Lori L. Alf

Founder & CEO, Tracking Innovations LLC, Founder & CEO, Palm Beach Ice Works and Member of the Board of Directors, National Air Cargo Group

Kenneth C. Anderson, MD, Scientific Founder

Kraft Family Professor of Medicine, Harvard Medical School, and Director of the Jerome Lipper Multiple Myeloma Center and Lebow Institute for Myeloma Therapeutics at the Dana-Farber Cancer Institute

James E. Bradner, MD, Scientific Founder

Assistant Professor of Medicine at Harvard Medical School and the Dana-Farber Institute

Bruce L. Downey, JD

Partner, NewSpring Health Capital, Radnor PA, former Chairman and CEO, Barr Pharmaceuticals, Inc., Chair, Board of Ambassadors for Johns Hopkins' Project RESTORE, and Member of the Boards of Directors, Cardinal Health and Momenta Pharmaceuticals

Walter C. Ogier

President & Chief Executive Officer, Acetylon Pharmaceuticals, Inc.

Elena A. Prokupets, PhD

Former President, Lenel Systems International (acquired by United Technologies), Member of the Board of Trustees, University of Rochester and Managing Director, The Metropolitan Opera of New York

William M. Scalzulli

Portfolio Manager, The Kraft Group

Ronald W. Kaiser

Board of Directors for the National Association of Corporate Directors – Greater Washington D.C Chapter,  Board and Committee Member of Tangoe Inc. (NASD:TNGO) since 2009, The NEAT COMPANY since 2012, and other private companies in software and drug discovery.